Top

Published in:

01-11-2016 | Editorial

Portal hypertensive gastropathy after variceal eradication: more bleeding risk or just more reddening?

Authors: Massimo Primignani, Giulia Tosetti

Published in: Hepatology International | Issue 6/2016

Excerpt

Portal hypertension may cause mucosal changes in the whole gastrointestinal tract, which may be the source of chronic or, more rarely, acute bleeding. Such changes often involve the stomach and, more rarely, the duodenum or the entire small bowel, and the colon. Major controversies on portal hypertensive gastropathy (PHG) regard its incidence, reported from 7 to 98 % [1‐6], the rates of PHG-related acute bleeds, reported from 2.7 to 44.6 % [1, 3, 6, 7], and its evolution after endoscopic treatment of esophageal varices. The last of these topics is addressed in the study by Elwakil et al. [8] recently published in Hepatology International. …

McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AJ, Triger DR. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26:1226–1232

Sarin SK, Misra SP, Singal A, Thorat V, Broor SL. Evaluation of the incidence and significance of the “mosaic pattern” in patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Am J Gastroenterol 1988; 83:1235–1239

D’Amico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spano` C, Pagliaro L, and the liver study group of V. Cervello Hospital. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990; 99:1558–1564

Cales P, Zabotto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H, Fermanian J, Pascal JP. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship with hepatic dysfunction. Gastroenterology 1990; 98:156–162

Sarin SK, Sreenivas DV, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology 1992; 102:994–999

Gostout CJ, Viggiano TR, Balm RK. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol 1993; 88:2030–2033

Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, De Franchis R. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000; 119(1):181–187

Elwakil R, Al Breedy AM, Gabal HH. Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study. Hepatol Int 2016; doi:10.1007/s12072-016-9711-z (Epub ahead of print)

Soares de Macedo GF, Gonçalves Ferreira F, Alves Ribeiro M, Szutan LA, Saab Assef M, Rossini GB. Reliability in endoscopic diagnosis of portal hypertensive gastropathy. World J Gastrointest Endosc. 2013; 16; 5(7):323–31

10.

Spina GP, Arcidiacono R, Bosch J, Pagliaro L, Burroughs AK, Santambrogio R, Rossi A. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol 1994; 21:461–467

11.

Sarin SK. Diagnostic issues: Portal hypertensive gastropathy and gastric varices. In: De Franchis R, editor. Portal hypertension II. Proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell, 1996:30–55

12.

Ward EM, Raimondo M, Rosser BG, Wallace MB, Dickson RD. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol 2004; 38:898–900

13.

Spahr L, Villeneuve JP, Dufresne MP, Tassé D, Bui B, Willems B, Fenyves D, Pomier-Layrargues G.. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44:739–42

14.

Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118:905–11

15.

Tobin RW, Hackman RC, Kimmey MB, Durtschi MB, Hayashi A, Malik R, McDonald MF, McDonald GB. Bleeding from gastric antral vascular ectasia in marrow transplant patients. Gastrointest Endosc 1996; 44:223–229

16.

Ingraham KM, O’Brien MS, Shenin M, Derk CT, Steen VD. Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol 2010; 37:603–607

17.

Stewart CA, Sanyal AJ. Grading portal gastropathy: validation of a gastropathy scoring system. Am J Gastroenterol 2003; 98:1758–1765

18.

Sarin SK, Shahi HM, Jain M, Jain AK, Issar SK, Murthy NS. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol 2000; 95:2888–2893

19.

Hou MC, Lin HC, Chen CH, Kuo BI, Perng CL, Lee FY, Lee SD. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc 1995; 42:139–144

20.

Lo GH, Lai KH, Cheng JS, Hsu PI, Chen TA, Wang EM, Lin CK, Chiang HT. The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. Gastrointest Endosc 2001; 53:579–584

21.

Hosking SW, Kennedy HJ, Seddon I, Triger DR. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 1987; 7:437–441

22.

Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991; 337:1431–1434

Title: Portal hypertensive gastropathy after variceal eradication: more bleeding risk or just more reddening?
Authors: Massimo Primignani
Giulia Tosetti
Publication date: 01-11-2016
Publisher: Springer India
Published in: Hepatology International / Issue 6/2016
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI: https://doi.org/10.1007/s12072-016-9750-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Portal hypertensive gastropathy after variceal eradication: more bleeding risk or just more reddening?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2016

Alcoholic hepatitis: should we combine old drugs for better results?

Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key

Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection

Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study

The potential role of liver stem cells in initiation of primary liver cancer

A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page